Revive Therapeutics Ltd (RVVTF)

[Fastlane2]

Let's put things in perspective and assume Revive gets their drug approved. Think global, hence why Revive has been working with Attwill Medical Solutions Sterilflow. The demand will outpace the manufacturing process and Revive's share price will over-shoot to the upside. $5. $7. $10. a share who knows but to be recalculated at 4/5 billion market cap is certainly not out of the question. The euphoria will be over the top, not just because of the approval but because of the 30 year history of the drug. Surveys have already indicated that people will either refuse or be hesitant on taking any medication related to Covid-19 however those patients with doubt will be reassured from their physicians that Bucillamine is safe.